Please enable JavaScript to continue using this application.

Compare $CRBU vs $SER | Chartloom

Compare

$CRBU vs $SER

Caribou Biosciences Inc · Serina Therapeutics Inc

CRBU

Caribou Biosciences Inc

SER

Serina Therapeutics Inc

Compare $CRBU vs $SER

Comparing Caribou Biosciences Inc and Serina Therapeutics Inc

CRBUCaribou Biosciences Inc

SERSerina Therapeutics Inc

CRBUCaribou Biosciences Inc

Market cap

$46M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

10.0%

YTD performance

-71.1%

52W performance

-82.8%

FCF yield

-210.7%

SERSerina Therapeutics Inc

Market cap

$30M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-3.8%

52W performance

-64.5%

FCF yield

-70.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CRBU

SER

Detailed metrics comparison

CRBU

Caribou Biosciences Inc

SER

Serina Therapeutics Inc

Market Cap

CRBU$46M

SER$30M

Enterprise Value

CRBU$19M

SER$10M

Price

CRBU$0.46

SER$2.00

P/E Ratio

CRBUN/A

SERN/A

P/S Ratio

CRBU4.55x

SER345.73x

EV/Sales

CRBU1.94x

SER207.28x

EV/EBITDA

CRBU0.00x

SER0.00x

P/B Ratio

CRBU1.33x

SER2.66x

P/FCF Ratio

CRBUN/A

SERN/A

EV/FCF

CRBU-0.20x

SER-0.47x

PEG Ratio

CRBUN/A

SERN/A

Forward P/E (NTM)

CRBUN/A

SERN/A

Forward P/S (NTM)

CRBUN/A

SERN/A

Revenue (TTM)

CRBU$10M

SER$0

Revenue Growth (YoY)

CRBU10.0%

SERN/A

Forward Rev Growth

CRBU15.8%

SER0.0%

Gross Margin (TTM)

CRBU0.0%

SER65.1%

Operating Margin (TTM)

CRBU0.0%

SER0.0%

EBITDA Margin (TTM)

CRBU-1065.1%

SER0.0%

Net Margin (TTM)

CRBU-1030.4%

SER0.0%

FCF Margin (TTM)

CRBU-958.5%

SERN/A

Net Income (TTM)

CRBU$-103M

SER$-17M

FCF (TTM)

CRBU$-96M

SER$-21M

EPS (TTM)

CRBU-$1.02

SER-$1.03

ROE (TTM)

CRBU-8911.0%

SER-10679.0%

ROA (TTM)

CRBU-6247.0%

SER-9480.0%

ROIC (TTM)

CRBU-8911.0%

SER-8268.0%

Cash

CRBU$26M

SER$23M

Debt

CRBU$0

SER$3M

Net Cash/Debt

CRBU$26M

SER$20M

Current Ratio (TTM)

CRBU6.49x

SER6.65x

Quick Ratio (TTM)

CRBU6.36x

SER6.12x

Debt/Equity (TTM)

CRBU0.00x

SER0.16x

Debt/Assets (TTM)

CRBU0.0%

SER0.0%

Interest Coverage (TTM)

CRBUN/A

SERN/A

Net Debt/EBITDA (TTM)

CRBU0.00x

SER0.00x

Beta

CRBU2.46

SER8.13

52W Performance

CRBU-82.8%

SER-64.5%

YTD Performance

CRBU-71.1%

SER-3.8%

% from 52W High

CRBU-87.0%

SER-65.0%

% from 52W Low

CRBU4.0%

SER63.9%

Asset Turnover (TTM)

CRBU0.06x

SER0.02x

FCF Yield (TTM)

CRBU-210.7%

SER-70.7%

Earnings Yield (TTM)

CRBU-226.5%

SER-56.2%

Dividend Yield (TTM)

CRBUN/A

SERN/A

Rule of 40

CRBU-948.5

SER0.0

EV/GP/RG

CRBUN/A

SERN/A

Ticker research

View CRBU research View SER research

Metric	CRBU Caribou Biosciences Inc	SER Serina Therapeutics Inc
Market & Valuation
Market Cap	$46M	$30M
Enterprise Value	$19M	$10M
Price	$0.46	$2.00
P/E Ratio	N/A	N/A
P/S Ratio	4.55x	345.73x
EV/Sales	1.94x	207.28x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.33x	2.66x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.20x	-0.47x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$10M	$0
Revenue Growth (YoY)	10.0%	N/A
Forward Rev Growth	15.8%	0.0%
Profitability
Gross Margin (TTM)	0.0%	65.1%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1065.1%	0.0%
Net Margin (TTM)	-1030.4%	0.0%
FCF Margin (TTM)	-958.5%	N/A
Net Income (TTM)	$-103M	$-17M
FCF (TTM)	$-96M	$-21M
EPS (TTM)	-$1.02	-$1.03
ROE (TTM)	-8911.0%	-10679.0%
ROA (TTM)	-6247.0%	-9480.0%
ROIC (TTM)	-8911.0%	-8268.0%
Financial Health
Cash	$26M	$23M
Debt	$0	$3M
Net Cash/Debt	$26M	$20M
Current Ratio (TTM)	6.49x	6.65x
Quick Ratio (TTM)	6.36x	6.12x
Debt/Equity (TTM)	0.00x	0.16x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.46	8.13
52W Performance	-82.8%	-64.5%
YTD Performance	-71.1%	-3.8%
% from 52W High	-87.0%	-65.0%
% from 52W Low	4.0%	63.9%
Efficiency & Yields
Asset Turnover (TTM)	0.06x	0.02x
FCF Yield (TTM)	-210.7%	-70.7%
Earnings Yield (TTM)	-226.5%	-56.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-948.5	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CRBU research	View SER research

Valuation

P/S Ratio

CRBU

4.55x

SER

345.73x

EV/FCF

SER

-0.47x

CRBU

-0.20x

Growth & revenue

Revenue Growth TTM

CRBU

10.0%

Forward Revenue Growth

CRBU

15.8%

SER

0.0%

Profitability & performance

Gross Margin

SER

65.1%

CRBU

0.0%

ROE

CRBU

-8911.0%

SER

-10679.0%

FCF Yield %

SER

-70.7%

CRBU

-210.7%

52-Week Performance

SER

-64.5%

CRBU

-82.8%

Detailed metrics comparison

CRBU

Caribou Biosciences Inc

SER

Serina Therapeutics Inc

Market Cap

CRBU$46M

SER$30M

Enterprise Value

CRBU$19M

SER$10M

Price

CRBU$0.46

SER$2.00

P/E Ratio

CRBUN/A

SERN/A

P/S Ratio

CRBU4.55x

SER345.73x

EV/Sales

CRBU1.94x

SER207.28x

EV/EBITDA

CRBU0.00x

SER0.00x

P/B Ratio

CRBU1.33x

SER2.66x

P/FCF Ratio

CRBUN/A

SERN/A

EV/FCF

CRBU-0.20x

SER-0.47x

PEG Ratio

CRBUN/A

SERN/A

Forward P/E (NTM)

CRBUN/A

SERN/A

Forward P/S (NTM)

CRBUN/A

SERN/A

Revenue (TTM)

CRBU$10M

SER$0

Revenue Growth (YoY)

CRBU10.0%

SERN/A

Forward Rev Growth

CRBU15.8%

SER0.0%

Gross Margin (TTM)

CRBU0.0%

SER65.1%

Operating Margin (TTM)

CRBU0.0%

SER0.0%

EBITDA Margin (TTM)

CRBU-1065.1%

SER0.0%

Net Margin (TTM)

CRBU-1030.4%

SER0.0%

FCF Margin (TTM)

CRBU-958.5%

SERN/A

Net Income (TTM)

CRBU$-103M

SER$-17M

FCF (TTM)

CRBU$-96M

SER$-21M

EPS (TTM)

CRBU-$1.02

SER-$1.03

ROE (TTM)

CRBU-8911.0%

SER-10679.0%

ROA (TTM)

CRBU-6247.0%

SER-9480.0%

ROIC (TTM)

CRBU-8911.0%

SER-8268.0%

Cash

CRBU$26M

SER$23M

Debt

CRBU$0

SER$3M

Net Cash/Debt

CRBU$26M

SER$20M

Current Ratio (TTM)

CRBU6.49x

SER6.65x

Quick Ratio (TTM)

CRBU6.36x

SER6.12x

Debt/Equity (TTM)

CRBU0.00x

SER0.16x

Debt/Assets (TTM)

CRBU0.0%

SER0.0%

Interest Coverage (TTM)

CRBUN/A

SERN/A

Net Debt/EBITDA (TTM)

CRBU0.00x

SER0.00x

Beta

CRBU2.46

SER8.13

52W Performance

CRBU-82.8%

SER-64.5%

YTD Performance

CRBU-71.1%

SER-3.8%

% from 52W High

CRBU-87.0%

SER-65.0%

% from 52W Low

CRBU4.0%

SER63.9%

Asset Turnover (TTM)

CRBU0.06x

SER0.02x

FCF Yield (TTM)

CRBU-210.7%

SER-70.7%

Earnings Yield (TTM)

CRBU-226.5%

SER-56.2%

Dividend Yield (TTM)

CRBUN/A

SERN/A

Rule of 40

CRBU-948.5

SER0.0

EV/GP/RG

CRBUN/A

SERN/A

Ticker research

View CRBU research View SER research

Metric	CRBU Caribou Biosciences Inc	SER Serina Therapeutics Inc
Market & Valuation
Market Cap	$46M	$30M
Enterprise Value	$19M	$10M
Price	$0.46	$2.00
P/E Ratio	N/A	N/A
P/S Ratio	4.55x	345.73x
EV/Sales	1.94x	207.28x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.33x	2.66x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.20x	-0.47x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$10M	$0
Revenue Growth (YoY)	10.0%	N/A
Forward Rev Growth	15.8%	0.0%
Profitability
Gross Margin (TTM)	0.0%	65.1%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1065.1%	0.0%
Net Margin (TTM)	-1030.4%	0.0%
FCF Margin (TTM)	-958.5%	N/A
Net Income (TTM)	$-103M	$-17M
FCF (TTM)	$-96M	$-21M
EPS (TTM)	-$1.02	-$1.03
ROE (TTM)	-8911.0%	-10679.0%
ROA (TTM)	-6247.0%	-9480.0%
ROIC (TTM)	-8911.0%	-8268.0%
Financial Health
Cash	$26M	$23M
Debt	$0	$3M
Net Cash/Debt	$26M	$20M
Current Ratio (TTM)	6.49x	6.65x
Quick Ratio (TTM)	6.36x	6.12x
Debt/Equity (TTM)	0.00x	0.16x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.46	8.13
52W Performance	-82.8%	-64.5%
YTD Performance	-71.1%	-3.8%
% from 52W High	-87.0%	-65.0%
% from 52W Low	4.0%	63.9%
Efficiency & Yields
Asset Turnover (TTM)	0.06x	0.02x
FCF Yield (TTM)	-210.7%	-70.7%
Earnings Yield (TTM)	-226.5%	-56.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-948.5	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CRBU research	View SER research